![Důležité termíny](https://cdn.muni.cz/media/3633704/image_2.jpg?mode=crop¢er=0.5,0.5&rnd=133572412150000000&heightratio=0.5&width=278)
Informace o publikaci
Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors
Autoři | |
---|---|
Rok publikování | 2012 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | Haemophilia |
Fakulta / Pracoviště MU | |
Citace | |
Doi | http://dx.doi.org/10.1111/j.1365-2516.2012.02920.x |
Obor | Onkologie a hematologie |
Klíčová slova | bleeding disorders; inhibitor |
Popis | Haemophilia registries, such as HemoRec, provide a valuable source of real-world data for the study of treatment modalities. We have reported that early treatment with rFVIIa appeared more effective than delayed-onset treatment in controlling the incidence of re-bleeding. The current study investigated whether time to treatment and/or initial dose of rFVIIa affects bleeding duration and, for the first time, their impact on acute pain control in inhibitor patients. |